sōna

Aspergillus GM Lateral Flow Assay

Invasive Aspergillosis is a serious threat—with over 30 million at-risk individuals annually¹, early detection is critical.

Time matters. IMMY’s Aspergillus GM LFA delivers highly sensitive and specific results in just 45 minutes, enabling clinicians to test more often and initiate timely treatment.
^{1) https://en.fungaleducation.org/invasive-aspergillosis-mucormycosis/}

Request Info

Product Documents

Specimen Types & Registrations

CE: Serum & BAL

Product Reference & Storage Conditions

AF2003
2-30°C

Detect Early. Treat Fast. Save Lives.

Features & Benefits

Results in just 45 MINUTES

Highly SENSITIVE & SPECIFIC

Test MORE OFTEN

Clinical Relevancy

Asp LFA Publication Findings²

The clinical performance of the IMMY sona Aspergillus Lateral Flow Assay in serum samples from cases classified as proven/probable/chronic IA/IFD (n=32) using EORTC/MSG criteria and control patients with no evidence of IFD (n=100).

In serum samples, the AGM LFA will correctly generate a positive result for 97% of patients with IA, and a negative result for 98% of patients without IA. The PPV shows that among patients with a positive AGM LFA result, the probability that they truly have IA is 94%. NPV shows that among patients with a negative AGM LFA result, the probability that they do not have IA is 99%.
_{2) Lewis W., et al. An evaluation of the performance of the IMMY sōna Aspergillus GM LFA when testing serum to aid in the diagnosis of IA. J Clin Micro. 2020; 00053-20.}

Clinical Relevancy

Asp LFA Publication Findings³

The diagnostic performance of the IMMY sona Aspergillus Lateral Flow Assay in BAL samples from hematology patients classified as proven IPA (n=11) using EORTC/MSG criteria and control patients with no evidence of IPA (n=117).

In BAL samples, the AGM LFA will correctly generate a positive result for 91% of patients with IA, and a negative result for 92% of patients without IA. The NPV shows that among patients with a negative AGM LFA result, the probability that they do not have IA is 99%.

_{3) Mercier T, et al. Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: A comparative multicenter study. Med Mycol. 2019.}